Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO)

Trial ID:
IRB-21-7777
Matthew J Price, M.D.
This study will look at closing the PFO to reduce the risk of another stroke using a commercial market-approved medical device called a septal occluder.
*Be 18-70 years of age<br>*Have been diagnosed with an ischemic stroke within the last 455 days<br>*Have the presence of a PFO<br>*Be willing and able to comply with protocol requirements, including follow-up visits

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org